Journal
BJU INTERNATIONAL
Volume 119, Issue 3, Pages 371-380Publisher
WILEY
DOI: 10.1111/bju.13760
Keywords
guidelines; management; non-muscle-invasive bladder cancer; #BladderCancer; #blcsm
Categories
Funding
- NIH T32 Ruth L. Kirschstein Institutional National Research Award
- Dedman Family Scholarship in Clinical Care
Ask authors/readers for more resources
Non-muscle-invasive bladder cancer (NMIBC) represents the vast majority of bladder cancer diagnoses, but this definition represents a spectrum of disease with a variable clinical course, notable for significant risk of recurrence and potential for progression. Management involves risk-adapted strategies of cystoscopic surveillance and intravesical therapy with the goal of bladder preservation when safe to do so. Multiple organizational guidelines exist to help practitioners manage this complicated disease process, but adherence to management principles among practising urologists is reportedly low. We review four major organizational guidelines on NMIBC: the American Urological Association (AUA)/Society of Urologic Oncology (SUO), European Association of Urology (EAU), National Comprehensive Cancer Network (NCCN), and National Institute for Health and Care Excellence (NICE) guidelines.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available